294 related articles for article (PubMed ID: 26445325)
1. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.
González-Ramos J; Sendagorta-Cudós E; González-López G; Mayor-Ibarguren A; Feltes-Ochoa R; Herranz-Pinto P
Dermatol Ther; 2016; 29(1):32-6. PubMed ID: 26445325
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pachyonychia congenita with plantar injections of botulinum toxin.
Swartling C; Vahlquist A
Br J Dermatol; 2006 Apr; 154(4):763-5. PubMed ID: 16536826
[TBL] [Abstract][Full Text] [Related]
3. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
[TBL] [Abstract][Full Text] [Related]
4. Mutations in a keratin 6 isomer (K6c) cause a type of focal palmoplantar keratoderma.
Bowden PE
J Invest Dermatol; 2010 Feb; 130(2):336-8. PubMed ID: 20081885
[TBL] [Abstract][Full Text] [Related]
5. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
[TBL] [Abstract][Full Text] [Related]
6. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
7. A treatment protocol for botulinum toxin injections in the treatment of pachyonychia congenita-associated keratoderma.
Koren A; Sprecher E; Reider E; Artzi O
Br J Dermatol; 2020 Mar; 182(3):671-677. PubMed ID: 31127950
[TBL] [Abstract][Full Text] [Related]
8. Pachyonychia congenita type 2: an unusual presentation.
Lo Schiavo A; Caccavale S; Alfano R; Romano F; Ruocco E
Am J Dermatopathol; 2013 Jul; 35(5):619-20. PubMed ID: 23249838
[No Abstract] [Full Text] [Related]
9. First case of pachyonychia congenita in the Czech Republic.
Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
[TBL] [Abstract][Full Text] [Related]
10. A new KRT16 mutation associated with a phenotype of pachyonychia congenita.
Paris F; Hurtado C; Azón A; Aguado L; Vizmanos JL
Exp Dermatol; 2013 Dec; 22(12):838-9. PubMed ID: 24118415
[TBL] [Abstract][Full Text] [Related]
11. Alleviation of the plantar discomfort caused by pachyonychia congenita with topical applications of aluminum chloride and salicylic acid ointments.
Takayama M; Okuyama R; Sasaki Y; Ohura T; Tagami H; Aiba S
Dermatology; 2005; 211(3):302. PubMed ID: 16205083
[No Abstract] [Full Text] [Related]
12. Recurrent mutation in keratin 17 in a large family with pachyonychia congenita type 2.
Oh Adib C; Jones B; Liao H; Smith FJ; Solomon R; Egan CA; Leachman S
Arch Dermatol Res; 2008 Jun; 300(5):211-4. PubMed ID: 18347808
[No Abstract] [Full Text] [Related]
13. Clinical and pathological features of pachyonychia congenita.
Leachman SA; Kaspar RL; Fleckman P; Florell SR; Smith FJ; McLean WH; Lunny DP; Milstone LM; van Steensel MA; Munro CS; O'Toole EA; Celebi JT; Kansky A; Lane EB
J Investig Dermatol Symp Proc; 2005 Oct; 10(1):3-17. PubMed ID: 16250204
[TBL] [Abstract][Full Text] [Related]
14. Pachyonychia Congenita: A Spectrum of KRT6a Mutations in Australian Patients.
Forrest CE; Casey G; Mordaunt DA; Thompson EM; Gordon L
Pediatr Dermatol; 2016 May; 33(3):337-42. PubMed ID: 27041546
[TBL] [Abstract][Full Text] [Related]
15. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
[TBL] [Abstract][Full Text] [Related]
16. Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation.
Sharma S; Dayal S; Aggarwal K; Gowda V M V; Kaur R
Australas J Dermatol; 2022 May; 63(2):e145-e149. PubMed ID: 35429339
[TBL] [Abstract][Full Text] [Related]
17. A large mutational study in pachyonychia congenita.
Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
[TBL] [Abstract][Full Text] [Related]
18. Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations.
Gruber R; Wilson NJ; Smith FJ; Grabher D; Steinwender L; Fritsch PO; Schmuth M
Br J Dermatol; 2009 Dec; 161(6):1391-5. PubMed ID: 19785597
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study.
Tan XL; Thomas BR; Steele L; Schwartz J; Hansen CD; O'Toole EA
J Am Acad Dermatol; 2022 Nov; 87(5):1172-1174. PubMed ID: 35245567
[No Abstract] [Full Text] [Related]
20. The phenotypic and molecular genetic features of pachyonychia congenita.
McLean WH; Hansen CD; Eliason MJ; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
